Watch GMED. Know when insiders buy.
One email the day a filing lands. Free.
GMED
GLOBUS MEDICAL INC
78.68
−0.28 −0.35%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
41
WATCH · insiders 25, shorts 57
Insiders, 90 days
−$2.2M
net selling · 0 buys, 1 sell
Congress, 90 days
2 / 0
buys / sells · latest disclosed Oct 12
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $10.6BP/E 20.2DIV YIELD —FCF YIELD 7.15%REV TTM $3.1B +19.7%NET INCOME $535.4M +50.1%NET CASH —52W 60.39 – 96.82SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $789.6M | +5.9% | 69.4% | $182.4M | $151.6M | −25.3% | 1.10 | $209.7M | $33.2M | $176.6M | Aug 6 |
| Q1 2026 · Mar 31 | $759.9M | +27.0% | 69.2% | $150.4M | $124.3M | +64.7% | 0.90 | $202.4M | $39.6M | $162.7M | May 7 |
| Q4 2025 · Dec 31derived | $826.4M | +25.7% | 68.4% | $169.3M | $140.6M | +430.4% | 1.02 | $248.6M | $46.2M | $202.4M | Feb 24 |
| Q3 2025 · Sep 30 | $769M | +22.9% | 67.2% | $137.4M | $119M | +129.5% | 0.88 | $249.7M | $35.8M | $213.9M | Nov 6 |
| Q2 2025 · Jun 30 | $745.3M | +18.4% | 66.6% | $76.1M | $202.8M | +538.7% | 1.49 | $77.9M | $46.6M | $31.3M | Aug 6 |
| Q1 2025 · Mar 31 | $598.1M | −1.4% | 67.3% | $97M | $75.5M | — | 0.54 | $177.3M | $36.1M | $141.2M | May 7 |
| Q4 2024 · Dec 31derived | $657.3M | +6.6% | 59.9% | $60.3M | $26.5M | +76.3% | 0.19 | $210.3M | $17.1M | $193.2M | Feb 24 |
| Q3 2024 · Sep 30 | $625.7M | +63.1% | 56.8% | $48.1M | $51.8M | +5094.0% | 0.38 | $203.7M | $42M | $161.7M | Nov 6 |
| Q2 2024 · Jun 30 | $629.7M | — | 58.7% | $49.6M | $31.8M | — | 0.23 | $54.3M | $27.8M | $26.5M | Aug 7 |
| Q1 2024 · Mar 31 | $606.7M | — | 60.2% | $8M | −$7.1M | — | -0.05 | $52.4M | $28.6M | $23.8M | May 8 |
| Q4 2023 · Dec 31derived | $616.5M | — | 56.9% | $10.1M | $15M | — | 0.09 | $104.7M | $22.9M | $81.8M | Feb 24 |
| Q3 2023 · Sep 30 | $383.6M | — | 64.7% | $404K | $998K | — | 0.01 | $50.5M | $21.5M | $28.9M | Nov 5 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $2.9B | 67.4% | $479.8M | $537.9M | 18.3% | 3.92 | $753.4M | $164.7M | $588.8M | $300.5M | — |
| FY2024 · to Dec 31 | $2.5B | 58.9% | $166M | $103M | 4.1% | 0.75 | $520.6M | $115.4M | $405.2M | $85.8M | — |
| FY2023 · to Dec 31 | $1.6B | 65.1% | $133.1M | $122.9M | 7.8% | 1.07 | $243.5M | $78.3M | $165.2M | $225.6M | — |
| FY2022 · to Dec 31 | $1B | 74.2% | $228M | $190.2M | 18.6% | 1.85 | $178.5M | $74M | $104.4M | $144.5M | — |
| FY2021 · to Dec 31 | $958.1M | 75.0% | $172M | $149.2M | 15.6% | 1.44 | $276.3M | $56.9M | $219.4M | — | — |
| FY2020 · to Dec 31 | $789M | 72.4% | $111.4M | $102.3M | 13.0% | 1.01 | $198.8M | $63.7M | $135.1M | $104.7M | — |
Every number comes from GLOBUS MEDICAL INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.